Published in J Am Coll Cardiol on March 11, 2008
Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis. Circulation (2015) 2.49
Updates in cardiac amyloidosis: a review. J Am Heart Assoc (2012) 2.21
Quantification of extracellular matrix expansion by CMR in infiltrative heart disease. JACC Cardiovasc Imaging (2012) 2.03
CMR imaging with rapid visual T1 assessment predicts mortality in patients suspected of cardiac amyloidosis. JACC Cardiovasc Imaging (2014) 1.57
Transthyretin (TTR) cardiac amyloidosis. Circulation (2012) 1.40
Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis. Am J Cardiol (2008) 1.31
Diagnostic and prognostic value of cardiovascular magnetic resonance in non-ischaemic cardiomyopathies. J Cardiovasc Magn Reson (2012) 1.17
2014 korean guidelines for appropriate utilization of cardiovascular magnetic resonance imaging: a joint report of the korean society of cardiology and the korean society of radiology. Korean Circ J (2014) 1.02
Cardiovascular magnetic resonance for amyloidosis. Heart Fail Rev (2015) 1.00
Amyloid in endomyocardial biopsies. Virchows Arch (2010) 1.00
Prognostic implication of late gadolinium enhancement on cardiac MRI in light chain (AL) amyloidosis on long term follow up. BMC Med Phys (2009) 0.99
Identifying the etiology: a systematic approach using delayed-enhancement cardiovascular magnetic resonance. Heart Fail Clin (2009) 0.96
Assessment of myocardial abnormalities in rheumatoid arthritis using a comprehensive cardiac magnetic resonance approach: a pilot study. Arthritis Res Ther (2010) 0.95
The role of cardiac magnetic resonance imaging in the assessment of non-ischemic cardiomyopathy. Heart Fail Rev (2011) 0.90
Incidence, diagnosis and prognosis of cardiac amyloidosis. Korean Circ J (2013) 0.90
How to image cardiac amyloidosis. Circ Cardiovasc Imaging (2014) 0.89
Prognostic impact of T2-weighted CMR imaging for cardiac amyloidosis. Eur Radiol (2011) 0.89
Assessment of cardiac ischaemia and viability: role of cardiovascular magnetic resonance. Eur Heart J (2011) 0.89
Intraventricular dyssynchrony in light chain amyloidosis: a new mechanism of systolic dysfunction assessed by 3-dimensional echocardiography. Cardiovasc Ultrasound (2008) 0.88
Late contrast enhancement by CMR: more than scar? Int J Cardiovasc Imaging (2008) 0.88
Cardiovascular magnetic resonance imaging of myocardial infarction, viability, and cardiomyopathies. Curr Probl Cardiol (2010) 0.87
Prevalence and prognosis of myocardial scar in patients with known or suspected coronary artery disease and normal wall motion. J Cardiovasc Magn Reson (2011) 0.86
The relative atrial volume ratio and late gadolinium enhancement provide additive information to differentiate constrictive pericarditis from restrictive cardiomyopathy. J Cardiovasc Magn Reson (2011) 0.85
Advances in Cardiovascular MRI for Diagnostics: Applications in Coronary Artery Disease and Cardiomyopathies. Expert Opin Med Diagn (2009) 0.83
Cardiovascular magnetic resonance in systemic hypertension. J Cardiovasc Magn Reson (2012) 0.82
Heart failure in patients with normal coronary anatomy: diagnostic algorithm and disease pattern of various etiologies as defined by cardiac MRI. Cardiovasc Diagn Ther (2012) 0.81
2014 Korean guidelines for appropriate utilization of cardiovascular magnetic resonance imaging: a joint report of the Korean Society of Cardiology and the Korean Society of Radiology. Korean J Radiol (2014) 0.81
Evaluation of hypertrophic cardiomyopathy: new horizons for CMR? Neth Heart J (2010) 0.81
Molecular phenotypes of human parvovirus B19 in patients with myocarditis. World J Cardiol (2014) 0.80
Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: diagnostic value of a typical pattern of late gadolinium enhancement. J Am Coll Cardiol (2008) 0.79
Late gadolinium enhancement in cardiac amyloidosis: attributable both to interstitial amyloid deposition and subendocardial fibrosis caused by ischemia. Heart Vessels (2015) 0.79
Investigation of cardiomyopathy using cardiac magnetic resonance imaging part 1: Common phenotypes. World J Cardiol (2012) 0.78
Cardiac magnetic resonance imaging in heart failure: where the alphabet begins! Heart Fail Rev (2017) 0.77
Noninvasive Identification of ATTRwt Cardiac Amyloid: The Re-emergence of Nuclear Cardiology. Am J Med (2015) 0.77
Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis. Int J Cardiovasc Imaging (2014) 0.77
Role of cardiac MRI in the assessment of nonischemic cardiomyopathies. Methodist Debakey Cardiovasc J (2013) 0.77
Recent advances in the noninvasive strategies of cardiac amyloidosis. Heart Fail Rev (2016) 0.77
A case of cardiac amyloidosis with diuretic-refractory pleural effusions treated with bevacizumab. Korean Circ J (2010) 0.75
Magnetic resonance imaging in the evaluation of congestive cardiac failure. Indian J Radiol Imaging (2012) 0.75
Role of Cardiac MR Imaging in Cardiomyopathies. J Nucl Med (2015) 0.75
Abnormal Myocardial Blood Flow Reserve Observed in Cardiac Amyloidosis. J Cardiovasc Ultrasound (2016) 0.75
Magnetic resonance imaging: a wealth of cardiovascular information. Ochsner J (2009) 0.75
Fast 3-Breath-Hold 3-Dimensional Tagging Cardiac Magnetic Resonance in Patients with Hypertrophic Myocardial Diseases: A Feasibility Study. Biomed Res Int (2016) 0.75
Application of cardiac magnetic resonance imaging in cardiomyopathy. Curr Heart Fail Rep (2008) 0.75
Severe Left Ventricular Hypertrophy, Small Pericardial Effusion, and Diffuse Late Gadolinium Enhancement by Cardiac Magnetic Resonance Suspecting Cardiac Amyloidosis: Endomyocardial Biopsy Reveals an Unexpected Diagnosis. Case Rep Cardiol (2016) 0.75
Impact of cardiac magnetic resonance imaging on cardiac device and surgical therapy: a prospective study. Int J Cardiovasc Imaging (2013) 0.75
Duchenne muscular dystrophy; a cardiomyopathy that can be prevented? Int J Cardiovasc Imaging (2008) 0.75
Advanced cardiac amyloidosis associated with normal interventricular septal thickness: an uncommon presentation of infiltrative cardiomyopathy. J Am Soc Echocardiogr (2014) 0.75
Cardiac magnetic resonance imaging as a prognostic tool in patients with nonischemic cardiomyopathy. Hosp Pract (1995) (2010) 0.75
Ischemic Hepatitis as the Presenting Manifestation of Cardiac Amyloidosis. J Investig Med High Impact Case Rep (2014) 0.75
Diagnostic accuracy of cardiovascular magnetic resonance for patients with suspected cardiac amyloidosis: a systematic review and meta-analysis. BMC Cardiovasc Disord (2016) 0.75
Classic images in cardiac magnetic resonance imaging: a case-based atlas highlighting current applications of cardiac magnetic resonance imaging. Curr Probl Cardiol (2009) 0.75
Practical applications of cardiovascular magnetic resonance. Heart Asia (2009) 0.75
A Heart too Stiff to Beat: A Case of Familial Transthyretin Amyloidosis Cardiomyopathy. Cureus (2017) 0.75
Uncharted waters: rare and unclassified cardiomyopathies characterized on cardiac magnetic resonance imaging. Insights Imaging (2010) 0.75
A patient with progressive dyspnoea. Neth Heart J (2015) 0.75
The Potential of Clinical Phenotyping of Heart Failure With Imaging Biomarkers for Guiding Therapies: A Focused Update. JACC Cardiovasc Imaging (2017) 0.75
A rare cause of cardiac decompensation in a patient with left ventricular hypertrophy. Clin Res Cardiol (2012) 0.75
Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics. J Cardiovasc Magn Reson (2017) 0.75
The Role of Cardiovascular Magnetic Resonance Imaging in Heart Failure. Card Fail Rev (2016) 0.75
Noninvasive detection of cardiac amyloidosis using delayed enhanced MDCT: a pilot study. Eur Radiol (2015) 0.75
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73
Universal definition of myocardial infarction. Circulation (2007) 11.69
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J (2013) 9.54
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2007) 9.43
Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59
European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J (2003) 8.51
Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol (2009) 6.41
European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2007) 6.10
Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J (2006) 5.79
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J (2014) 5.21
Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J (2005) 4.62
Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat Med (2008) 4.54
Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation (2004) 4.23
Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat Genet (2002) 3.90
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J (2013) 3.50
European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2003) 3.43
Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol (2010) 3.20
Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation (2006) 3.20
Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol (2002) 3.14
Update on myocarditis. J Am Coll Cardiol (2012) 3.12
High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction. Circulation (2005) 3.06
Impact of remote telemedical management on mortality and hospitalizations in ambulatory patients with chronic heart failure: the telemedical interventional monitoring in heart failure study. Circulation (2011) 2.87
European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2007) 2.70
Clinical usefulness, angiographic characteristics, and safety evaluation of intracoronary acetylcholine provocation testing among 921 consecutive white patients with unobstructed coronary arteries. Circulation (2014) 2.65
Long-term survival in patients presenting with type B acute aortic dissection: insights from the International Registry of Acute Aortic Dissection. Circulation (2006) 2.56
Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus. Nat Immunol (2011) 2.51
Coronary artery spasm as a frequent cause of acute coronary syndrome: The CASPAR (Coronary Artery Spasm in Patients With Acute Coronary Syndrome) Study. J Am Coll Cardiol (2008) 2.48
Impaired renal Na(+) retention in the sgk1-knockout mouse. J Clin Invest (2002) 2.47
Simple risk models to predict surgical mortality in acute type A aortic dissection: the International Registry of Acute Aortic Dissection score. Ann Thorac Surg (2007) 2.44
The reno-vascular A2B adenosine receptor protects the kidney from ischemia. PLoS Med (2008) 2.43
Right ventricular involvement in Takotsubo cardiomyopathy. Eur Heart J (2006) 2.28
Gender-related differences in acute aortic dissection. Circulation (2004) 2.24
High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries. The ACOVA Study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries). J Am Coll Cardiol (2012) 2.24
EuroCMR (European Cardiovascular Magnetic Resonance) registry: results of the German pilot phase. J Am Coll Cardiol (2009) 2.23
Value of cardiovascular magnetic resonance stress perfusion testing for the detection of coronary artery disease in women. JACC Cardiovasc Imaging (2008) 2.03
Predictors of outcome in patients with suspected myocarditis. Circulation (2008) 2.03
Parvovirus B19 infection mimicking acute myocardial infarction. Circulation (2003) 2.03
Diagnostic synergy of non-invasive cardiovascular magnetic resonance and invasive endomyocardial biopsy in troponin-positive patients without coronary artery disease. Eur Heart J (2009) 1.98
Acute adverse reactions to gadolinium-based contrast agents in CMR: multicenter experience with 17,767 patients from the EuroCMR Registry. JACC Cardiovasc Imaging (2011) 1.93
Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury. FASEB J (2007) 1.84
Connective tissue growth factor: a crucial cytokine-mediating cardiac fibrosis in ongoing enterovirus myocarditis. J Mol Med (Berl) (2007) 1.83
Impact of the hepatitis B virus genotype and genotype mixtures on the course of liver disease in Vietnam. Hepatology (2006) 1.82
Cardiac deletion of the Coxsackievirus-adenovirus receptor abolishes Coxsackievirus B3 infection and prevents myocarditis in vivo. J Am Coll Cardiol (2009) 1.81
Diagnostic performance of CMR imaging compared with EMB in patients with suspected myocarditis. JACC Cardiovasc Imaging (2012) 1.77
Acute intramural hematoma of the aorta: a mystery in evolution. Circulation (2005) 1.76
High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. Am J Obstet Gynecol (2005) 1.73
Differential use of importin-α isoforms governs cell tropism and host adaptation of influenza virus. Nat Commun (2011) 1.65
European Cardiovascular Magnetic Resonance (EuroCMR) registry--multi national results from 57 centers in 15 countries. J Cardiovasc Magn Reson (2013) 1.60
Long-term survival in patients presenting with type A acute aortic dissection: insights from the International Registry of Acute Aortic Dissection (IRAD). Circulation (2006) 1.57
Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery. J Am Coll Cardiol (2012) 1.53
Training and accreditation in cardiovascular magnetic resonance in Europe: a position statement of the working group on cardiovascular magnetic resonance of the European Society of Cardiology. Eur Heart J (2011) 1.53
[Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation]. G Ital Cardiol (Rome) (2009) 1.52
Highly pathogenic influenza virus infection of the thymus interferes with T lymphocyte development. J Immunol (2010) 1.51
Detection of high-risk human papillomavirus E6 and E7 oncogene transcripts in cervical scrapes by nested RT-polymerase chain reaction. J Med Virol (2004) 1.50
Protease-activated receptor-2 regulates the innate immune response to viral infection in a coxsackievirus B3-induced myocarditis. J Am Coll Cardiol (2013) 1.50
Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation. Nat Med (2010) 1.49
Humoral anti-proteasomal autoimmunity in dilated cardiomyopathy. Basic Res Cardiol (2010) 1.47
Images in cardiovascular medicine. Cardiomyopathy in a Duchenne muscular dystrophy carrier and her diseased son: similar pattern revealed by cardiovascular MRI. Circulation (2010) 1.47
Giant cell myocarditis mimicking idiopathic fascicular ventricular tachycardia. J Heart Lung Transplant (2008) 1.46
Fatal parvovirus B19 myocarditis in an 8-year-old boy. J Forensic Sci (2003) 1.45
Myocardial gene expression profiles and cardiodepressant autoantibodies predict response of patients with dilated cardiomyopathy to immunoadsorption therapy. Eur Heart J (2012) 1.44